Ignite Creation Date:
2025-12-24 @ 6:49 PM
Ignite Modification Date:
2025-12-26 @ 11:09 AM
Study NCT ID:
NCT01051557
Status:
COMPLETED
Last Update Posted:
2021-07-19
First Post:
2010-01-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-01-27
Start Date Type:
ACTUAL
Primary Completion Date:
2018-11-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-09-30
Completion Date Type:
ACTUAL
First Submit Date:
2010-01-15
First Submit QC Date:
None
Study First Post Date:
2010-01-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-03-17
Results First Submit QC Date:
None
Results First Post Date:
2016-04-18
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-06-28
Last Update Post Date:
2021-07-19
Last Update Post Date Type:
ACTUAL